Neurotensin (CAS 39379-15-2): A Precision Neurotensin Rec...
Neurotensin (CAS 39379-15-2): A Precision Neurotensin Receptor 1 Activator for GPCR Trafficking Studies
Executive Summary: Neurotensin is a 13-amino acid neuropeptide that selectively activates Neurotensin receptor 1 (NTR1), a G protein-coupled receptor (GPCR) expressed in the central nervous system and gut [APExBIO product page]. Upon NTR1 binding, Neurotensin modulates microRNA expression, notably upregulating miR-133α in human colonic epithelial cells, impacting receptor recycling via AFTPH protein targeting. The APExBIO B5226 product is supplied at ≥98% purity, validated by HPLC and MS, with solubility ≥15.33 mg/mL (DMSO) and ≥22.55 mg/mL (water). It is insoluble in ethanol and must be stored desiccated at -20°C for maximal stability. These properties make Neurotensin a preferred tool for dissecting GPCR trafficking and miRNA regulation in gastrointestinal and neural research (Zhang et al., 2024).
Biological Rationale
Neurotensin is an endogenous tridecapeptide (pGlu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu) primarily secreted in the central nervous system and gastrointestinal tract. Its function as a neurotransmitter and paracrine modulator is mediated by high-affinity binding to NTR1, a prototypical class A GPCR (APExBIO). NTR1 is highly expressed in the brainstem, hypothalamus, and intestinal epithelium. Neurotensin signaling regulates intestinal motility, pain perception, and inflammatory responses. In colonic epithelial cells, Neurotensin influences microRNA (miRNA) networks, including miR-133α, which targets proteins involved in receptor trafficking and endosomal recycling. These pathways are critical for the spatial and temporal control of GPCR signaling in both physiological and pathological states (see also: high-purity NTR1 activator for advanced experimental design; this article expands on miRNA aspects).
Mechanism of Action of Neurotensin (CAS 39379-15-2)
Neurotensin exerts its effects through selective activation of NTR1, triggering canonical GPCR signaling cascades. Upon ligand binding, NTR1 undergoes conformational change, activating intracellular G-proteins (primarily Gq/11). This induces phospholipase C activation, inositol triphosphate (IP3) production, and intracellular calcium release. Downstream, Neurotensin modulates gene expression, including upregulation of miR-133α. In colonic epithelial models, this miRNA downregulates aftiphilin (AFTPH), a vesicle trafficking protein essential for receptor recycling via endosomal and trans-Golgi network compartments. The net effect is altered NTR1 surface expression and trafficking kinetics. These mechanisms have been characterized in cell-based and animal models, demonstrating high specificity of Neurotensin for NTR1 over related GPCRs (contrast: this scenario-driven guide focuses on troubleshooting assay interference, while here we detail molecular signaling).
Evidence & Benchmarks
- Neurotensin (CAS 39379-15-2) is a validated 13-amino acid peptide with a molecular mass of 1672.94 Da and formula C78H121N21O20 (APExBIO B5226).
- NTR1 is expressed at high levels in both CNS and intestinal epithelial tissues, as demonstrated by immunohistochemistry and transcriptomics (Zhang et al., 2024).
- Neurotensin binding to NTR1 initiates Gq/11-coupled signaling, leading to PLC activation and IP3-mediated Ca2+ release (see Figure 2, Zhang et al., 2024).
- Exposure to Neurotensin upregulates miR-133α in human colonic epithelial cells, as quantified by qPCR and miRNA arrays (Zhang et al., 2024).
- miR-133α directly targets aftiphilin (AFTPH), reducing its expression and modulating receptor recycling via endosomal/TGN pathways (see Table 4, Zhang et al., 2024).
- B5226 is insoluble in ethanol but soluble at ≥15.33 mg/mL in DMSO and ≥22.55 mg/mL in water (data sheet: APExBIO).
- Purity is ≥98% (HPLC and MS-verified), supporting sensitive GPCR and miRNA assays (see: gold standard for purity; this article details solubility and storage).
- Use of spectral transformation and advanced algorithms, such as Fast Fourier Transform, reduces interference in fluorescence-based peptide quantification by 9.2%, increasing classification accuracy to 89.24% (Zhang et al., 2024).
Applications, Limits & Misconceptions
Neurotensin (CAS 39379-15-2) is a robust tool for:
- Dissecting GPCR trafficking and recycling mechanisms in neural and intestinal models.
- Elucidating microRNA-mediated regulation, specifically miR-133α, in receptor signaling networks.
- Validating fluorescent or EEM-based assays with minimal spectral interference due to high purity formulation.
- Supporting translational studies in gastrointestinal motility, pain, and inflammation.
For a systems-biology perspective on these topics, see this overview, which this article extends by providing unit-quantitative reagent specifications and validated workflow parameters.
Common Pitfalls or Misconceptions
- Incorrect solvent selection: Neurotensin is insoluble in ethanol; use DMSO (≥15.33 mg/mL) or water (≥22.55 mg/mL) for stock solutions (APExBIO).
- Assuming long-term stability in solution: Prepared solutions degrade; use fresh stocks for each experiment and avoid prolonged storage (>24 h).
- Expectation of direct effect on all GPCRs: Neurotensin is highly selective for NTR1 and does not activate unrelated GPCRs.
- Neglecting bioaerosol interference in fluorescence assays: Use spectral preprocessing and transformation to minimize pollen or protein interference in bioanalytical workflows (Zhang et al., 2024).
- Overlooking microRNA specificity: Only certain miRNAs (e.g., miR-133α) are modulated by Neurotensin in verified cell models.
Workflow Integration & Parameters
For optimal use, dissolve APExBIO B5226 in DMSO or water to concentrations of at least 15.33 mg/mL and 22.55 mg/mL, respectively. Store all lyophilized material desiccated at -20°C. Avoid freeze-thaw cycles. For GPCR trafficking and miRNA regulation studies, typical cell-based assay concentrations range from 10 nM to 1 μM, with incubation times of 10 min to 24 h, depending on experimental endpoint. Preprocessing of fluorescence spectra is recommended to control for interference, using normalization, multivariate scattering correction (MSC), and/or Savitzky–Golay smoothing. Classification algorithms, such as random forest or partial least squares discriminant analysis, further improve assay specificity (Zhang et al., 2024).
For detailed troubleshooting and real-world integration, this scenario-driven guide offers evidence-based solutions to reagent compatibility and workflow optimization; this article clarifies the physicochemical underpinnings and storage specifics.
Conclusion & Outlook
Neurotensin (CAS 39379-15-2) is a validated, high-purity tool for probing NTR1-dependent GPCR trafficking and miRNA regulatory networks in gastrointestinal and neural systems. APExBIO’s B5226 product offers robust physicochemical properties, supporting reproducible biochemistry and advanced cell signaling research. Integration of spectral preprocessing and machine learning further enhances experimental precision by minimizing interference. Future work may focus on extending miRNA regulatory profiling and refinements in assay sensitivity across diverse tissue models.